BioSpace News Archive

FDA

Breckenridge Pharmaceutical, Inc. Announces Final ANDA Approval For Armodafinil Tablets (CIV) In 50mg, 150mg And 250 Mg Strengths (Nuvigil)

November 29, 2016
·
2 min read
Drug Development

Windtree Therapeutics’ AEROSURF (Lucinactant For Inhalation) Phase 2a Data Presented At The 2016 International Congress Of Union Of European Neonatal And Perinatal Societies

November 29, 2016
·
4 min read
Drug Development

CytRx Reports Statistically Significant Updated Results From Pivotal Phase 3 Trial Of Aldoxorubicin In Patients With Second-Line Soft Tissue Sarcomas

November 29, 2016
·
10 min read
Drug Development

Jazz Pharma Announces That Patient Enrollment Is Complete For The Phase 3 Study Of JZP-110 Evaluating Excessive Sleepiness In Narcolepsy

November 29, 2016
·
4 min read
Drug Development

Vtesse Receives Rare Pediatric Disease Designation By The FDA For VTS-270 For The Treatment Of Niemann-Pick Type C1 Disease

November 29, 2016
·
3 min read
Business

AMRI Announces API Supply Agreement With Shire

November 29, 2016
·
1 min read
Biotech Beach

Emmaus Life Sciences Receives Notice Of FDA PDUFA Date For Investigational L-Glutamine Treatment For Sickle Cell Disease

November 29, 2016
·
4 min read
Drug Development

Oramed’s ORMD-0901 (Oral GLP-1 Analog) Found Safe And Well Tolerated In Phase Ib Study

November 29, 2016
·
4 min read
Biotech Beach

SomaGenics Inc. Granted New Patents For RNA Detection And RNA-Based Therapeutics Technologies

November 29, 2016
·
2 min read
Biotech Bay

BioPharmX Announces Closing Of A $12.5 Million Unit Offering

November 29, 2016
·
4 min read